Abstract
Although corneal transplantation is very successful for keratoconus and some other dystrophies, it is not nearly as successful for acquired corneal opacities. The usual cause of failure is allograft rejection. In high-risk cases a number of strategies are required to decrease the risk of rejection. These include suppression of inflammation, MHC matching, and local and systemic immunosuppression. For the results of corneal transplantation to improve, surgeons must be prepared to choose from a range of approaches, those best suited to the individual patient.
Similar content being viewed by others
Article PDF
References
Keats RH, and Falkenstein S : Kerotoplasty in keratoconus. Am J Ophthalmol 1972; 74: 442–4.
Coster DJ : Factors affecting the outcome of corneal transplantation. Ann Royal Coll Surg Eng 1981; 63: 91–7.
Storb R, and Thomas ED : Immunol Rev 1983; 71:77–102.
Deeg HJ, Storb R, Gerhard-Miller L, Shulman HM, Weiden PL, Thomas ED : Transplantation 1980; 29: 230.
Barker CF, and Billingham RE : Immunologically privileged sites and tissues. In Porter R, Knight J. eds. Corneal Graft Failure. Ciba Foundation Symposium 15 (new series). Amsterdam: Elsevier, Excerpta Medica, North Holland 1973: 79–104.
Peto R, Pike MC, Armitage P, Breslow NE : Cox DR, Howard SV, Mantel N . McPherson K, Peto J, Smith PG . Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35:1–39.
Williams KA, Sawyer M, Alfrich SJ, Joseph L, White M, Coster DJ (eds): First report of the Australian corneal graft registry. Aust NZ Ophthalmol 1987; 15: 291–302.
Fujikawa LS, Colvin RB, Bhan AK, Fuller TC, Foster CS : Expression of HLA-A/B/C and DR locus antigens on epithelial, stromal and endothelial cells of the human cornea. Cornea 1982; 1: 213–22.
Mayer DJ, Daar AS, Casey TA, Fabre JW : Localization of HLA-A,B,C and HLA-DR antigens in the human cornea: practical significance for grafting technique and HLA typing. Transplant Proc 1983; 15: 126–9.
Whitsett CF, and Stulting RD : The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci 1984; 25: 519–24.
Treseler PA, Foulks GN, Sanfilippo F : The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol 1984; 98: 753–72.
Williams KA, Ash JK, Coster DJ : Histocom-patibility antigen and passenger cell content of normal and diseased human cornea. Transplantation 1985; 39: 265–9.
Klareskog L, Forsum U, Tjernlund VM, Rask L, Peterson PA : Expression of Ia antigen-like molecules on cells in the corneal epithelium. Invest Ophthalmol Vis Sci 1979; 18: 310–13.
Rodrigues MM, Rowden G, Hackett J, Bakos I : Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci 1981; 21: 759–65.
Gillette TE, Chandler JW, Greiner JV : Langerhans cells of the ocular surface. Ophthalmol 1982; 89: 700–11.
Young E, Stark WJ, Prendergast RA : Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells. Invest Ophthalmol Vis Sci 1985; 26: 571–74.
Donnelly JJ, Li W, Rockey JH, Prendergast RA : Induction of class II (Ia) alloantigen expression on corneal endothelium in vivo and in vitro. Invest Ophthalmol Vis Sci 1985; 26: 575–80.
Williams KA, Mann TS, Lewis M, Coster DJ : The role of resident accessory cells in corneal allograft rejection in the rabbit. Transplantation 1986; 42: 667–71.
Steinman RM, and Nussenzweig MC : Dendritic cells: features and functions. Immunol Rev 1980; 53:127–47.
Lafferty KJ, Andrus L, Prouse SJ : Role of lymphokine and antigen in the control of specific T cell responses. Immunol Rev 1980; 51: 279–314.
Dallman MJ, and Mason DW : Induction of Ia antigens of murine epidermal cells during the rejection of skin allografts. Transplantation 1983; 36: 222–4.
Hall BM, Bishop GA, Duggin GG, Horvath JS, Phillips J, Tiller DJ : Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection process. Lancet 1984; 2: 247–5l.
Barclay AN, and Mason DW : Induction of Ia antigen in rat epidermal cells and gut epithelium by immunological stimuli. J Exp Med 1982; 156:1665–76.
Prober JS, Gimbrone MA, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA : Ia expression by vascular endothelium is inducible by activated T cells and by human interferons. J Exp Med 1983; 157: 1339–53.
Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW : Inducible expression of H-2 and Ia antigens on brain cells. Nature 1984; 310: 688–9l.
Lechler RI, and Batchelor JR : Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31–4l.
Sherwood RA, Brent L, Rayfield LS : Presentation of alloantigens by host .cells. Eur J Immunol 1986; 16: 569–74.
Mason DW, and Morris PJ : Effector mechanisms in allograft rejection. Am Rev Immunol 1986; 4: 119–45.
Opremcak EM, Whisler RL, Dangel ME : Natural killer cells against human corneal endothelium. Am J Ophthalmol 1985; 99: 524–9.
Polack FM : Lymphocyte destruction during corneal homograft reaction. A scanning electron microscopic study. Arch Ophthalmol 1973; 89: 413–16.
Basu PK, and Carre F : A study of cells in human corneal grafts. Growth potential in vitro cellular morphology, and fate of donor cells. Canad J Ophthal 1973; 8:1–9.
Batchelor JR, Casey TA, Gibbs DC, Lloyd DF, Werb A, Prasad SS, James A : HLA matching and corneal grafting. Lancet 1976; 1: 551–4.
Stark WJ, Taylor HR, Bias WB, Maumenee AE : Histocompatibility (HLA) antigens and keratoplasty. Am J Ophthalmol 1978; 86: 595–604.
Foulks G, and Sanfilippo F : Beneficial effects of histocompatibility in high-risk corneal transplantation. Am J Ophthalmol 1982; 94: 622–9.
Sanfilippo F, MacQueen JM, Vaughn WK, Foulks GN : Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation. New Engl J Med 1986; 315: 29–35.
Volker-Dieben HJM, D'Amaro J, Kok -van Alphen CC : Hierarchy of prognostic factors for corneal allograft survival. Aust NZ J Ophthalmol 1987; 15: 11–18.
Boisjoly HM, Roy R, Dube I, Laughrea PA, Michaud R, Douvill JP, Hebert J : HLA-A, B and DR matching in corneal transplantation. Ophthalmology 1986: 93: 1290–7.
Tuberville AW, Foster CS, Wood TO : The effect of donor cornea epithelium removal on the incidence of allograft rejection reactions. Ophthalmology 1983; 90: 1351–6.
Lafferty KJ, Bootes A, Dart G, Talmage DW : Effect of organ culture on the survival of thyroid allografts in mice. Transplantation 1976; 22: 138–49.
Simeonovic CJ, Bowen KM, Kotlarski I, Lafferty KJ : Modulation of tissue immunogenicity by organ culture. Comparison of adult islets and foetal pancreas. Transplantation 1980; 30: 174–9.
Williams KA, Ash JK, Mann TS, Noonan FP, Coster DJ : Cells infiltrating inflamed and vas-cularized corneas. Transplant Proc 1987; 19: 2889–9l.
Ray-Keil L, and Chandler JW : Reduction in the incidence of rejection of heterotopic murine corneal transplants by pretreatment with ultraviolet radiation. Transplantation 1986; 42: 403–6.
Rees AJ, and Lockwood CM : Immunosuppressive drugs in clinical practice. In Lachman P, Peters DK eds. Clinical aspects of immunology, 4th ed. Oxford: Blackwell Scientific Publications 1982; 1:507–24.
Sherach EM : The effects of cyclosporin A on the immune system. Ann Rev Immunol 1985; 3: 397–423.
Kupiec-Weglinski JW, Filho MA, Strom TB, Tilney NL : Sparing of suppressor cells: a cutical action of cyclosporine. Transplantation 1984; 38: 97–10l.
Coster DJ, Shepherd WFI, Fook TC, Rice NSC, Jones BR : Prolonged survival of corneal allografts in rabbits treated with cyclosporin A. Lancet 1979; 2: 688–9.
Shepherd WFI, Coster DJ, Fook TC, Rice NSC, Jones BR : Effect of cyclosporin A on the survival of corneal grafts in rabbits. Br J Ophthalmol 1980; 64: 148–53.
Bell TAG, Easty DL, McCullagh KG : A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft rejection in rabbits. Br J Ophthalmol 1982; 66: 303–8.
Hunter PA, Wilhelmus KR, Rice NSC, Jones BR : Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection. Clin Exp Immunol 1981; 45: 173–7.
Kana JS, Hoffman F, Buchen R, Krolik A, Wiederholt M : Rabbit corneal allograft survival following topical administration of cyclosporin A. Invest Ophthalmol Vis Sci 1982; 22: 686–90.
Hunter PA, Garner A, Wilhelmus KR, Rice NSC, Jones BR : Corneal graft rejection: a new rabbit model and cyclosporin A. Br J Ophthalmol 1982; 66: 292–302.
Williams KA, Grutzmacher RD, Roussel TJ, Coster DJ : A comparison of the effects of topical cyclosporine and topical steroid on rabbit corneal allograft rejection. Transplantation 1985; 39: 242–4.
Williams KA, Erickson SA, Coster DJ : Topical steroid, cyclosporin A, and the outcome of rat corneal allografts. Br J Ophthalmol 1987; 71: 239–42.
Palestine AG, Nussenblatt RB, Chan CC : Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 1984 77:652–6.
Ippoliti G, and Fronterre : Use of locally injected anti-T monoclonal antibodies in the treatment of acute corneal graft rejection. Transplant Proc 1987; 19: 2579–80.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coster, D. Mechanisms of corneal graft failure : The erosion of corneal privilege. Eye 3, 251–262 (1989). https://doi.org/10.1038/eye.1989.35
Issue Date:
DOI: https://doi.org/10.1038/eye.1989.35
This article is cited by
-
Graft failure: III. Glaucoma escalation after penetrating keratoplasty
International Ophthalmology (2008)
-
Histocompatibility antigens
Eye (1995)
-
Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients
Documenta Ophthalmologica (1993)
-
The success and survival of repeat corneal grafts
Eye (1990)
-
Intraocular surgery following penetrating keratoplasty: The risks and advantages
Eye (1990)